Civeo Corp 8-K

What Happened
Civeo Corporation announced on July 7, 2026 that it completed a private, unregistered offering of $100.0 million aggregate principal amount of 4.50% Convertible Senior Notes due 2031 (the “Notes”), issued under an Indenture with U.S. Bank Trust Company, N.A. The Company received approximately $96.2 million of net proceeds, used about $22.3 million to repurchase 660,297 common shares concurrently with pricing, and intends to use the remaining proceeds to repay borrowings under its Amended and Restated Syndicated Facility Agreement. The initial purchasers have a 13‑day option to buy up to an additional $15.0 million of Notes.

Key Details

• Size & timing: $100.0M principal issued July 7, 2026; initial purchasers can buy up to an additional $15.0M within 13 days.
• Net proceeds & use: ~$96.2M net; ~$22.3M used to repurchase 660,297 common shares; remainder to repay syndicated facility borrowings.
• Terms: 4.50% interest, paid semi‑annually (Feb 1 and Aug 1), first payment Feb 1, 2027; maturity Aug 1, 2031.
• Conversion mechanics & dilution: initial conversion rate 24.6840 common shares per $1,000 principal (≈ $40.51 per share); maximum shares issuable 2,962,080 (3,406,392 if option exercised). Conversion consideration may be cash, shares, or a mix.
• Redemption & conversion windows: Company generally cannot redeem before Aug 1, 2029 (except tax/cleanup redemptions); optional redemption allowed after Aug 1, 2029 if share price tests are met (generally >130% of conversion price per specific trading‑day tests). Limited conversion rights prior to May 1, 2031; unrestricted conversion possible on or after May 1, 2031 until two business days before maturity.
• Protective features: holders may require repurchase on a defined fundamental change; Indenture contains customary default and bankruptcy/delisting protections.

Why It Matters
This transaction raises near‑term liquidity for Civeo while replacing syndicated bank borrowings with convertible debt. The offering reduces bank leverage (proceeds will repay facility borrowings) and immediately reduced share count via a concurrent $22.3M share repurchase. However, the Notes could convert into up to 2.96 million shares (more if the purchase option is exercised), representing potential dilution if conversions occur. Investors should watch Civeo’s leverage metrics, interest expense, and the company’s share price relative to the conversion price ($40.51), which affects the likelihood and timing of conversion or company redemption.